Prostate Cancer News on BioPortfolio

$VERU Initiates Clinical Trial for Proprietary Novel FirstinClass Drug for Advanced Prostate Cancer httpsglobenewswire.comnewsrelease2019012217034500enVeruInitiatesClinicalTrialforProprietaryNovelFirstinClassDrugforAdvancedPro

$VERU Initiates Clinical Trial for Proprietary Novel FirstinClass Drug for Advanced Prostate Cancer httpsglobenewswire.comnewsrelease2019012217034500enVeruInitiatesClinicalTrialforProprietaryNovelFirstinClassDrugforAdvancedProstateCancer.html &hellip...

PSA screening reduces prostate cancer deaths by 30

PSAscreening cuts deaths from prostate cancer by some 30. This is shown by research based on data on 20000 men monitored for more than two decades. The men's initially measured PSA level proved highly significant as a predictor of future cancer risk.

OptraSCANÂ Announces Expansion of Medical Advisory Board

Strategic medical advisors appointed to guide on neuropathology immunology and molecular pathology research OptraSCANÂ the leading OnDemand Digital Pathology solution provider today announced the expansion o...

Thirty percent fewer prostate cancer deaths with PSA screening

University of Gothenburg PSA screening cuts deaths from prostate cancer by some 30 percent. This is shown by research based on data on 20000 men monitored for more than two decades. The men's initially measured PSA level proved highly significant as a pred...

Gene Responsible for Spread of Prostate Cancer Identified

NewsA study has found that a specific gene in cancerous prostate tumors indicates when patients are at highrisk for the cancer to spread suggesting that targeting this gene can help patients live longer.

European Commission approves prostate cancer treatment Erleada

Erleada apalutamide has been approved for nonmetastatic castrationresistant prostate cancer patients who are at high risk of developing metastatic diseaseThe post European Commission approves prostate cancer treatment Erleada appeared first on European Pha...

Scientist identifies gene responsible for spread of prostate cancer

A Rutgers study has found that a specific gene in cancerous prostate tumours indicates when patients are at highrisk for the cancer to spread suggesting that targeting this gene can help patients live longer.The study which was published in the...

Pages